Looking to buy shares Monday and looking at the 1/22 15C options. I expect OSCR to struggle a little to get through 18.5 but when through I expect the mid 20's to trade.
Insider activity: www.tipranks.com
OSCR in Daily still bearish but we just begun an incertitude phase. It is preferable to wait before to identify the new direction.
Positifs signals we are waiting for:
• Break the range by superior limit
• Ichimoku composant cross the cloud (Price, chninkou and tenken
In the other hand we have Two supports to see : 16.42 and 15.40
NYSE:OSCR
Possible Scenario: LONG
Evidence: Price Action,
Entry Point : 17.30$
Call options, strike 20$, 10/15/2021.
*This is my idea and could be wrong 100%.
We are forming a daily chart bull flag pennant on OSCR. With the recent 5-5.5 rise in this stock look for a continuation to probably 22-23 range if we break resistance at 18.5
Multiple cluster buys from CEO and Directorship over the last couple of months - most recent 17SEPT. Purely technical play set up for breakout - synthetic long. PT is 21.70 which is a result of my own fundamentals and tech analysis. Primary motivation is the ongoing insider buying and tech set up of price action.
I see the trend is up after the earnings and I noticed the CEO bought +57,300 shares which indicates to me they know something. I'm going to say this stock may rebound back to the $34 range.
I'm liking the volume the past 3 days. Could be reversal time.
Got a long position at 13.13. Looks like it's already up 1.5% just in the time I drew the chart out
IPO intraday trading strategy idea
Oscar Health is tech-enabled medical insurance provider.
The share price is falling and gonna continue this trend today.
The demand for shares of the company still looks lower than the supply.
These and other conditions can cause a fall in the share price today.
So I opened a short position from $36;
stop-loss —...
Oscar Health, Inc. operates as a health insurance company which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.
NYSE
